Description
Background:
Sintilimab, sold under the brand Tyvyt among others, is a medication used to treat Hodgkin’s disease. It is a fully human IgG4 monoclonal antibody[4] that binds to programmed cell death protein 1
Intended Use:
For Estimation of Sintilimab (TYVYT) in human serum and plasma. Please note the kit has not been optimized to be used for any other animal species. Should you require a specific sera tested, please connect with us at sales@krishgen.com for optimization.
If you have published a paper by using any of our ELISA since 01/01/2023, kindly fill out the “Krishgen Publication Reward Application Form” with complete information and send it by at email: info@krishgen.com, with the subject “Krishgen Publication Reward”. We will get back to you with the Amazon / Krishgen Credit Reward after we confirm it ASAP!